Evidence map›Paper›PMID 33946771›Full record

ReviewCells2021

Molecular Functions of WWOX Potentially Involved in Cancer Development.

Karim Taouis, Keltouma Driouch, Rosette Lidereau, François Lallemand

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Article
  2. Article
  3. WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Endothelial knockdown of the tumor suppressor,American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  9. Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.International journal of molecular sciences · 2024
    Review
  10. Frontiers in pediatrics · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karim TaouisPharmacogenomics Unit, Department of Genetics, Institut Curie, 75005 Paris, France.
Keltouma DriouchPharmacogenomics Unit, Department of Genetics, Institut Curie, 75005 Paris, France.
Rosette LidereauPharmacogenomics Unit, Department of Genetics, Institut Curie, 75005 Paris, France.
François LallemandPharmacogenomics Unit, Department of Genetics, Institut Curie, 75005 Paris, France.
Institut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The WW domain-containing oxidoreductase gene (

Indexed as

AnimalsCarcinogenesisCell DeathGene Expression Regulation, NeoplasticGenomic InstabilityHumansWarburg Effect, OncologicWW Domain-Containing OxidoreductaseWW Domain-Containing Oxidoreductasecancersmolecular functionsWWOX

Identifiers

PMID33946771
PMCPMC8145924
OpenAlexW3158071307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.